Rogier M. Reijmers

1.9k total citations
33 papers, 1.1k citations indexed

About

Rogier M. Reijmers is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Rogier M. Reijmers has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 14 papers in Molecular Biology and 13 papers in Hematology. Recurrent topics in Rogier M. Reijmers's work include Immune Cell Function and Interaction (9 papers), Proteoglycans and glycosaminoglycans research (9 papers) and T-cell and B-cell Immunology (8 papers). Rogier M. Reijmers is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Proteoglycans and glycosaminoglycans research (9 papers) and T-cell and B-cell Immunology (8 papers). Rogier M. Reijmers collaborates with scholars based in Netherlands, Sweden and United States. Rogier M. Reijmers's co-authors include Marcel Spaargaren, Steven T. Pals, Reina E. Mebius, Robert H.J. Beelen, Mirjam H.M. Heemskerk, Marjolein van Egmond, Annemieke Kuil, Jasper J. Koning, J.H. Frederik Falkenburg and Jan G. J. van de Winkel and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Rogier M. Reijmers

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rogier M. Reijmers Netherlands 21 577 438 325 194 160 33 1.1k
Geneviève Fiol France 13 489 0.8× 489 1.1× 328 1.0× 412 2.1× 83 0.5× 16 1.1k
Kirsten Neubert Germany 10 483 0.8× 414 0.9× 177 0.5× 230 1.2× 115 0.7× 13 1.0k
Hussein Al‐Mossawi United Kingdom 17 594 1.0× 341 0.8× 278 0.9× 234 1.2× 48 0.3× 51 1.2k
Gijs Hardenberg Netherlands 13 841 1.5× 263 0.6× 179 0.6× 65 0.3× 71 0.4× 18 1.2k
Annabelle M. Friera United States 13 437 0.8× 580 1.3× 312 1.0× 269 1.4× 64 0.4× 18 1.1k
Bellinda A. Bladergroen Netherlands 17 471 0.8× 399 0.9× 200 0.6× 111 0.6× 75 0.5× 19 1.0k
Seong Hoe Park South Korea 22 612 1.1× 373 0.9× 350 1.1× 74 0.4× 59 0.4× 62 1.4k
Marion Baudard France 18 312 0.5× 541 1.2× 369 1.1× 686 3.5× 141 0.9× 34 1.3k
Cathy Quilici Australia 16 698 1.2× 259 0.6× 239 0.7× 141 0.7× 33 0.2× 18 1.1k
Consuelo Anzilotti United Kingdom 17 389 0.7× 455 1.0× 258 0.8× 60 0.3× 48 0.3× 24 1.1k

Countries citing papers authored by Rogier M. Reijmers

Since Specialization
Citations

This map shows the geographic impact of Rogier M. Reijmers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rogier M. Reijmers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rogier M. Reijmers more than expected).

Fields of papers citing papers by Rogier M. Reijmers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rogier M. Reijmers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rogier M. Reijmers. The network helps show where Rogier M. Reijmers may publish in the future.

Co-authorship network of co-authors of Rogier M. Reijmers

This figure shows the co-authorship network connecting the top 25 collaborators of Rogier M. Reijmers. A scholar is included among the top collaborators of Rogier M. Reijmers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rogier M. Reijmers. Rogier M. Reijmers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paijmans, Joris, et al.. (2024). Advances in preclinical TCR characterization: leveraging cell avidity to identify functional TCRs. Biological Chemistry. 405(7-8). 517–529. 2 indexed citations
2.
Grab, Anna Luise, Peter Kim, Lukas John, et al.. (2024). Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma. Cells. 13(10). 879–879. 5 indexed citations
3.
Houdt, Michel van, Karin Schornagel, Paul J.J.H. Verkuijlen, et al.. (2023). SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity. International Journal of Molecular Sciences. 24(24). 17141–17141. 5 indexed citations
4.
Koning, Jasper J., Rogier M. Reijmers, Tanja Konijn, et al.. (2021). Development of follicular dendritic cells in lymph nodes depends on retinoic acid-mediated signaling. Development. 148(20). 4 indexed citations
5.
Reijmers, Rogier M., Rob N. de Jong, Dennis F.G. Remst, et al.. (2021). An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML. Cancers. 13(21). 5390–5390. 11 indexed citations
6.
Keuning, Eelco D., Jasper J. Koning, Sander de Kivit, et al.. (2020). Lymph Node Stromal Cells Generate Antigen-Specific Regulatory T Cells and Control Autoreactive T and B Cell Responses. Cell Reports. 30(12). 4110–4123.e4. 54 indexed citations
7.
Morton, Laura T., Rogier M. Reijmers, Anne K. Wouters, et al.. (2019). Simultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic. Molecular Therapy. 28(1). 64–74. 54 indexed citations
8.
Reijmers, Rogier M., Renate S. Hagedoorn, Rob C. M. de Jong, et al.. (2019). Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia. Journal of Clinical Investigation. 129(2). 774–785. 127 indexed citations
9.
Bar‐Ephraïm, Yotam E., Jasper J. Koning, Tanja Konijn, et al.. (2018). CD62L Is a Functional and Phenotypic Marker for Circulating Innate Lymphoid Cell Precursors. The Journal of Immunology. 202(1). 171–182. 40 indexed citations
10.
Digre, Andreas, K. N. Singh, Magnus Åbrink, et al.. (2017). Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis. Scientific Reports. 7(1). 46229–46229. 29 indexed citations
11.
Bar‐Ephraïm, Yotam E., Ferry Cornelissen, Natalie Papazian, et al.. (2017). Cross-Tissue Transcriptomic Analysis of Human Secondary Lymphoid Organ-Residing ILC3s Reveals a Quiescent State in the Absence of Inflammation. Cell Reports. 21(3). 823–833. 33 indexed citations
12.
Celie, Johanna W.A.M., Wynand B.W.H. Melenhorst, Rogier M. Reijmers, et al.. (2012). Tubular epithelial syndecan-1 maintains renal function in murine ischemia/reperfusion and human transplantation. Kidney International. 81(7). 651–661. 53 indexed citations
13.
Reijmers, Rogier M., Richard W.J. Groen, Annemieke Kuil, et al.. (2011). Disruption of heparan sulfate proteoglycan conformation perturbs B-cell maturation and APRIL-mediated plasma cell survival. Blood. 117(23). 6162–6171. 45 indexed citations
14.
Cornelissen, Ferry, et al.. (2011). Activation and effector functions of human RORC+ innate lymphoid cells. Current Opinion in Immunology. 23(3). 361–367. 9 indexed citations
15.
Groen, Richard W.J., Martin F. M. de Rooij, Kinga A. Kocemba‐Pilarczyk, et al.. (2011). N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation. Haematologica. 96(11). 1653–1661. 32 indexed citations
16.
Reijmers, Rogier M., Mark F. R. Vondenhoff, Ramon Roozendaal, et al.. (2010). Impaired Lymphoid Organ Development in Mice Lacking the Heparan Sulfate Modifying Enzyme Glucuronyl C5-Epimerase. The Journal of Immunology. 184(7). 3656–3664. 22 indexed citations
17.
Reijmers, Rogier M., Richard W.J. Groen, Henk Rozemuller, et al.. (2009). Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma. Blood. 115(3). 601–604. 40 indexed citations
18.
Reijmers, Rogier M., Richard W.J. Groen, Henk Rozemuller, et al.. (2009). Targeting EXT-1 Reveals a Crucial Role of Heparan Sulfate in the Growth of Multiple Myeloma.. Blood. 114(22). 1830–1830. 3 indexed citations
19.
Celie, Johanna W.A.M., Rogier M. Reijmers, Ed Slot, et al.. (2007). Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria. American Journal of Physiology-Renal Physiology. 294(1). F253–F263. 38 indexed citations
20.
Otten, Marielle A., Michael Dechant, Cornelis W. Tuk, et al.. (2005). Immature Neutrophils Mediate Tumor Cell Killing via IgA but Not IgG Fc Receptors. The Journal of Immunology. 174(9). 5472–5480. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geneviève Fiol Breakdown of academic impact, for papers by Kirsten Neubert Breakdown of academic impact, for papers by Hussein Al‐Mossawi Breakdown of academic impact, for papers by Gijs Hardenberg Breakdown of academic impact, for papers by Annabelle M. Friera Breakdown of academic impact, for papers by Bellinda A. Bladergroen Breakdown of academic impact, for papers by Seong Hoe Park Breakdown of academic impact, for papers by Marion Baudard Breakdown of academic impact, for papers by Cathy Quilici Breakdown of academic impact, for papers by Consuelo Anzilotti
Rankless by CCL
2026